Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Trial to Evaluate the Safety and Efficacy of Chloral Hydrate in Patients with Severe Insomnia

NCT06053840 is registered in ClinicalTrials.gov with Pharmanovia as lead sponsor.

NCT NCT06053840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06053840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Trial to Evaluate the Safety and Efficacy of Chloral Hydrate in Patients with Severe Insomnia
Lead sponsor
Pharmanovia
Phase
Phase 4
Overall status
Completed
Start date
September 1, 2023
Completion date
May 7, 2024
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chloral hydrate, insomnia, insomnia chronic